Drug intelligence / Profile preview

alnus serrulata pollen

Development stage
Unknown
Lead developer
Greer Laboratories
Administration
Percutaneous, Intradermal, Inhalation, Intranasal, Ophthalmic
01

Overview

Alnus serrulata pollen is a non-standardized allergenic extract derived from the pollen of the hazel alder (or tag alder) tree, which is native to the eastern United States. Manufactured by Greer Laboratories, this biological product is used for both the diagnosis and treatment of Type I hypersensitivity reactions. In diagnostic settings, it is utilized in percutaneous or intradermal skin testing to identify patients with hazel alder pollen sensitivity. Therapeutically, it is administered via subcutaneous allergen immunotherapy (AIT), where repeated exposure to increasing doses of the allergen aims to induce immunological tolerance. This process typically involves shifting the immune response from a Th2-mediated allergic profile to a Th1-mediated or regulatory T cell-driven response, thereby reducing symptoms of allergic rhinitis, conjunctivitis, and asthma.

Brand names
Hazel Alder Pollen
Other names
Tag Alder PollenHazel Alder Pollen Extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on alnus serrulata pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alnus serrulata pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call